Home > Healthcare > Analytical Instruments > Molecular Analysis > Nucleic Acid Amplification Testing Market

Nucleic Acid Amplification Testing Market Share

Report ID: GMI8506
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Nucleic Acid Amplification Testing Market Share

The nucleic acid amplification testing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Nucleic Acid Amplification Testing Market Companies

Some of the eminent market participants operating in the nucleic acid amplification testing industry include:

Abbott Laboratories
Becton, Dickinson and Company
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann La Roche AG
Illumina, Inc.
QIAGEN N.V.
Seegene Inc.
Siemens Healthineers AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global nucleic acid amplification testing market was valued at around USD 7.3 billion in 2023 and is estimated to reach over USD 18.8 billion by 2032, driven by the increasing prevalence of diseases such as HIV/AIDS, tuberculosis, hepatitis, and sexually transmitted infections.

The infectious disease testing segment is estimated to account for USD 8.9 billion by 2032, favored by the global prevalence of infectious diseases and the emergence of new pathogens.

In 2023, North America held a significant market share of 40.8%, attributed to the proactive regulatory frameworks and robust reimbursement policies in the region.

Abbott Laboratories, Becton, Dickinson, and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann La Roche AG, Illumina, Inc., QIAGEN N.V., Seegene Inc., and Siemens Healthineers AG.